Zentalis Pharmaceuticals (ZNTL) SEC Filings & 10K Form

Zentalis Pharmaceuticals logo
$2.16 +0.08 (+3.85%)
Closing price 02/12/2025 04:00 PM Eastern
Extended Trading
$2.26 +0.09 (+4.40%)
As of 02/12/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Zentalis Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/11/2025
7:06 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
5:29 PM
EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:30 PM
Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:31 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:32 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:33 PM
Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:37 PM
EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:06 PM
MILLENNIUM MANAGEMENT LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/03/2025
6:12 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:13 PM
Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:14 PM
Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
11:44 AM
Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/31/2025
9:09 AM
VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/29/2025
8:18 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
9:08 AM
Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/08/2025
5:49 PM
Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/10/2024
11:42 AM
Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/06/2024
10:44 AM
FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/03/2024
6:02 PM
EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:02 PM
Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:44 PM
Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:45 PM
EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM
Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM
Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:06 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
1:47 PM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
11/04/2024
1:16 PM
VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
7:59 PM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
11:50 AM
STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/07/2024
10:37 AM
FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/04/2024
5:01 PM
Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:02 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:01 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:03 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2024
4:06 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:07 PM
Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:09 PM
Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:11 PM
Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:00 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
5:27 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:28 PM
Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Has Trump finally met his match? (Ad)

Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?

Click here for his emergency broadcast...
05/29/2024
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:16 AM
Zentalis Pharmaceuticals (Filer)
Form DEFA14A
05/29/2024
6:33 AM
Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2024
6:34 AM
Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:46 PM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:47 PM
HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
6:03 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:05 AM
Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
3:34 PM
Zentalis Pharmaceuticals (Filer)
Form DEF 14A
04/29/2024
3:36 PM
Zentalis Pharmaceuticals (Filer)
Form DEFA14A
04/11/2024
6:00 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
6:02 AM
Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
3:30 PM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:14 PM
Zentalis Pharmaceuticals (Filer)
Form S-3ASR
02/29/2024
4:20 PM
Zentalis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
6:04 AM
Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:08 AM
Zentalis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2024
6:43 PM
Avidity Partners Management LP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ZNTL) was last updated on 2/13/2025 by MarketBeat.com Staff
From Our Partners